Plasmodium berghei K173: Selection of resistance to naphthoquine in a mouse model

Experimental Parasitology - Tập 127 - Trang 436-439 - 2011
Hong Wang1, Zhu-Chun Bei1, Jing-Yan Wang1, Wu-Chun Cao2
1Department of Pharmacy, Beijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, 100071 Beijing, PR China
2Department of Epidemiology and Health Statistics, Beijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, 100071 Beijing, PR China

Tài liệu tham khảo

Congpuong, 2010, Compliance with a three-day course of artesunate–mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria, Malaria Journal, 9, 43, 10.1186/1475-2875-9-43 Cooper, 2005, Pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective, Acta Tropica, 94, 170, 10.1016/j.actatropica.2005.04.004 Cowman, 1994, Selection of mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistant to halofantrine and quinine, Proceedings of the National Academy of Sciences, 91, 1143, 10.1073/pnas.91.3.1143 Ferrer-Rodriguez, 2004, Plasmodium yoelii: identification and partial characterization of an mdr1 gene in an artemisinin-resistant line, Journal of Parasitology, 90, 152, 10.1645/GE-3225 Fidock, 2000, Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Molecular Cell, 6, 861, 10.1016/S1097-2765(05)00077-8 Foote, 1989, Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum, Cell, 57, 921, 10.1016/0092-8674(89)90330-9 Gadalla, 2010, Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum, Malaria Journal, 9, 74, 10.1186/1475-2875-9-74 Hastings, 2004, The origins of antimalarial drug resistance, Trends in Parasitology, 20, 512, 10.1016/j.pt.2004.08.006 Hombhanje, 2009, Artemisinin–naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy, Malaria Journal, 8, 196, 10.1186/1475-2875-8-196 Hyde, 2007, Drug-resistant malaria—an insight, FEBS Journal, 274, 4688, 10.1111/j.1742-4658.2007.05999.x Kiboi, 2009, Plasmodium berghei ANKA: Selection of resistance to piperaquine and lumefantrine in a mouse model, Experimental Parasitology, 122, 196, 10.1016/j.exppara.2009.03.010 Li, 1985, Development of piperaquine-resistant line of Plasmodium berghei ANKA strain, Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, 3, 189 Li, 1985, Development of a piperaquine-resistant line of Plasmodium berghei K 173 strain, Yao Xue Xue Bao, 20, 412 Li, 1998, The development of chloroquine-resistant line of Plasmodium berghei Keyberg 173 strain, Jun Shi Yi Xue Ke Xue Yuan Yuan Kan, 13, 118 Merkli, 1980, Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model, Acta Tropica, 37, 228 Nzila, 2006, Inhibitors of de novo folate enzymes in Plasmodium falciparum, Drug Discovery Today, 11, 939, 10.1016/j.drudis.2006.08.003 Peters, 1975, The chemotherapy of rodent malaria. XXII. The value of drug-resistant strains of P. berghei in screening for blood Schizonticidal activity, Annals of Tropical Medicine and Parasitology, 69, 155, 10.1080/00034983.1975.11686997 Peters, 1999, The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, Part 1: Which model is appropriate?, Annals of Tropical Medicine and Parasitology, 93, 569, 10.1080/00034989958087 Picot, 2009, A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria, Malaria Journal, 8, 89, 10.1186/1475-2875-8-89 Puri, 2006, Plasmodium vinckei: selection of a strain exhibiting stable resistance to arteether, Experimental Parasitology, 114, 129, 10.1016/j.exppara.2006.02.017 Preechapornkul, 2009, Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness, Antimicrobial Agents and Chemotherapy, 53, 1509, 10.1128/AAC.00241-08 Price, 2004, Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, 364, 438, 10.1016/S0140-6736(04)16767-6 Price, 2009, New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance, Current Opinion in Infectious Diseases, 22, 430, 10.1097/QCO.0b013e32832f14c1 Qu, 2010, Single-dose safety, pharmacokinetics, and food effects studies of compound naphthoquine phosphate tablets in healthy volunteers, Journal of Clinical Pharmacology, 10.1177/0091270009356296 Räth, 2004, Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood), American Journal of Tropical Medicine and Hygiene, 70, 128, 10.4269/ajtmh.2004.70.128 Rujumba, 2010, A comparative study of Arco and Coartem in the treatment of uncomplicated malaria in patients aged 4 months to 16 years attending Mulago hospital, Kampala, Uganda, International Journal of Medical Microbiology, 14, e332 Rungsihirunrat, 2009, Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand, Acta Tropica, 109, 37, 10.1016/j.actatropica.2008.09.011 Sidhu, 2002, Chloroquine resistance in Plasmodium falciparum cholroquine malaria parasites conferred by pfcrt mutations, Science, 298, 210, 10.1126/science.1074045 Sidhu, 2006, Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin, Journal of Infectious Diseases, 194, 528, 10.1086/507115 Snow, 2005, The global distribution of clinical episodes of Plasmodium falciparum malaria, Nature, 434, 214, 10.1038/nature03342 Suwanarusk, 2007, Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms, PLoS One, 2, e1089, 10.1371/journal.pone.0001089 Syafruddin, 1999, Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone, Molecular and Biochemical Parasitology, 104, 185, 10.1016/S0166-6851(99)00148-6 Tun, 2009, Efficacy of oral single dose therapy with artemisinin-naphthoquine phosphate in uncomplicated falciparum malaria, Acta Tropica, 111, 275, 10.1016/j.actatropica.2009.05.007 Wang, 2004, Naphthoquine phosphate and its combination with artemisinine, Acta Tropica, 89, 375, 10.1016/j.actatropica.2003.11.008 White, 2004, Antimalarial drug resistance, Journal of Clinical Investigation, 113, 1084, 10.1172/JCI21682 Wong, 2010, In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea, Tropical Medicine and International Health, 35, 342, 10.1111/j.1365-3156.2009.02463.x Wongsrichanalai, 2002, Epidemiology of drug-resistant malaria, Lancet Infectious Diseases, 2, 209, 10.1016/S1473-3099(02)00239-6 Wykes, 2009, What have we learnt from mouse models for the study of malaria?, European Journal of Immunology, 39, 2004, 10.1002/eji.200939552 Zhang, 2009, The polymorphisms of Pfcrt 72–76 in Plasmodium falciparum isolated from China and their relationships with chloroquine resistance, Zhongguo Ren Shou Gong Huan Bing Za Zhi, 25, 725